Popular gut probiotic craps out in randomized controlled trial
A randomized, triple‑blind trial of a popular single‑strain gut probiotic for chronic constipation found no benefit over placebo, prompting doubts about heavily marketed “gut health” supplements. Commenters contrast this with anecdotal success using specific strains for IBS and with traditional fermented foods like yogurt, sauerkraut, and kombucha, which offer greater microbial diversity. The exchange also raises broader points about placebo effects, hydration, over‑processed diets (especially in the US versus Europe), and how media headlines can overstate what a narrowly focused clinical study actually shows.
Reactions to headline and coverage
- Many enjoyed the punny headline but some felt the article and title were misleading or clickbait.
- Several argued the piece overgeneralizes from a narrow trial (“this strain, in this population, for this problem”) to “probiotics don’t work.”
- A few commenters expressed broader fatigue with the outlet’s drift toward politics/pop-culture and sensational framing.
Study design, limits, and statistics
- Trial tested a single strain (Bifidobacterium animalis subsp. lactis) for chronic constipation, in a specific population.
- Both probiotic and placebo groups significantly improved bowel movements; the probiotic did not outperform placebo.
- Some see this as evidence the product is ineffective; others stress that “non‑significant” ≠ “no effect,” and that small or narrow studies can’t rule out all benefits.
- One commenter notes the sponsor had incentive to find a positive result, so a null finding is notable.
Effectiveness of probiotics
- A gastroenterologist in the thread reports most probiotics are expensive placebos, with a few exceptions for specific conditions (e.g., C. difficile, ulcerative colitis).
- Others report strong personal benefit from certain strains or multi‑strain formulations (e.g., L. reuteri, VSL#3‑like mixes), especially for IBS‑type symptoms.
- Several emphasize huge individual variability, poorly understood “dysbiosis,” and weak clinical tools to match strains to patients.
Diet, fermented foods, and geography
- Multiple anecdotes claim better gut health when living in Europe, attributed variously to:
- Fewer additives, sweeteners, and preservatives.
- Different regulations on food chemicals.
- More traditional, less ultra‑processed diets.
- There is debate over how different EU/US food regulations really are (E‑numbers vs named additives) and whether “we’ve always eaten it” counts as evidence.
- Many advocate fermented foods (yogurt, kefir, sauerkraut, kimchi, kombucha) and microbial diversity over single‑strain supplements; some cite popular science summaries supporting this.
Hydration, lifestyle, and other factors
- Commenters note both trial arms’ bowel movements more than doubled, suggesting hydration or general behavior change (e.g., taking a pill with water, feeling “treated”) might matter.
- Placebo effects are highlighted as real, potentially useful tools rather than just noise.
- Other speculative contributors to gut issues mentioned: artificial sweeteners, rinse aids/dishwasher detergents, stress (gut–brain axis), and overall low‑quality, ultra‑processed diets.